Khudhairet al[126] demonstrated thatN. brasiliensis ESPs significantly reduced glucose tolerance and body weight in a mouse model of type 2 diabetes, likely mediated by the increase of eosinophilia and IL-5 in peripheral tissues, showing its therapeutic potential for treating some metabolic disorders. This evidence concerns the gene IL5 and Increased total eosinophil count.